533 related articles for article (PubMed ID: 23000189)
1. Ultrasound-mediated blood-brain/blood-tumor barrier disruption improves outcomes with trastuzumab in a breast cancer brain metastasis model.
Park EJ; Zhang YZ; Vykhodtseva N; McDannold N
J Control Release; 2012 Nov; 163(3):277-84. PubMed ID: 23000189
[TBL] [Abstract][Full Text] [Related]
2. Growth inhibition in a brain metastasis model by antibody delivery using focused ultrasound-mediated blood-brain barrier disruption.
Kobus T; Zervantonakis IK; Zhang Y; McDannold NJ
J Control Release; 2016 Sep; 238():281-288. PubMed ID: 27496633
[TBL] [Abstract][Full Text] [Related]
3. Enhancement in blood-tumor barrier permeability and delivery of liposomal doxorubicin using focused ultrasound and microbubbles: evaluation during tumor progression in a rat glioma model.
Aryal M; Park J; Vykhodtseva N; Zhang YZ; McDannold N
Phys Med Biol; 2015 Mar; 60(6):2511-27. PubMed ID: 25746014
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of permeability, doxorubicin delivery, and drug retention in a rat brain tumor model after ultrasound-induced blood-tumor barrier disruption.
Park J; Aryal M; Vykhodtseva N; Zhang YZ; McDannold N
J Control Release; 2017 Mar; 250():77-85. PubMed ID: 27742444
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of enhanced drug delivery in brain metastases with focused ultrasound-induced blood-tumor barrier disruption.
Arvanitis CD; Askoxylakis V; Guo Y; Datta M; Kloepper J; Ferraro GB; Bernabeu MO; Fukumura D; McDannold N; Jain RK
Proc Natl Acad Sci U S A; 2018 Sep; 115(37):E8717-E8726. PubMed ID: 30150398
[TBL] [Abstract][Full Text] [Related]
6. Multiple treatments with liposomal doxorubicin and ultrasound-induced disruption of blood-tumor and blood-brain barriers improve outcomes in a rat glioma model.
Aryal M; Vykhodtseva N; Zhang YZ; Park J; McDannold N
J Control Release; 2013 Jul; 169(1-2):103-11. PubMed ID: 23603615
[TBL] [Abstract][Full Text] [Related]
7. Multiple sessions of liposomal doxorubicin delivery via focused ultrasound mediated blood-brain barrier disruption: a safety study.
Aryal M; Vykhodtseva N; Zhang YZ; McDannold N
J Control Release; 2015 Apr; 204():60-9. PubMed ID: 25724272
[TBL] [Abstract][Full Text] [Related]
8. Targeting microbubbles-carrying TGFβ1 inhibitor combined with ultrasound sonication induce BBB/BTB disruption to enhance nanomedicine treatment for brain tumors.
Chen YC; Chiang CF; Wu SK; Chen LF; Hsieh WY; Lin WL
J Control Release; 2015 Aug; 211():53-62. PubMed ID: 26047759
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic approaches for HER2-positive brain metastases: circumventing the blood-brain barrier.
Mehta AI; Brufsky AM; Sampson JH
Cancer Treat Rev; 2013 May; 39(3):261-9. PubMed ID: 22727691
[TBL] [Abstract][Full Text] [Related]
10. Improved anti-tumor effect of liposomal doxorubicin after targeted blood-brain barrier disruption by MRI-guided focused ultrasound in rat glioma.
Treat LH; McDannold N; Zhang Y; Vykhodtseva N; Hynynen K
Ultrasound Med Biol; 2012 Oct; 38(10):1716-25. PubMed ID: 22818878
[TBL] [Abstract][Full Text] [Related]
11. Modulation of KCa channels increases anticancer drug delivery to brain tumors and prolongs survival in xenograft model.
Ningaraj NS; Sankpal UT; Khaitan D; Meister EA; Vats TS
Cancer Biol Ther; 2009 Oct; 8(20):1924-33. PubMed ID: 19738431
[TBL] [Abstract][Full Text] [Related]
12. Acoustic feedback enables safe and reliable carboplatin delivery across the blood-brain barrier with a clinical focused ultrasound system and improves survival in a rat glioma model.
McDannold N; Zhang Y; Supko JG; Power C; Sun T; Peng C; Vykhodtseva N; Golby AJ; Reardon DA
Theranostics; 2019; 9(21):6284-6299. PubMed ID: 31534551
[TBL] [Abstract][Full Text] [Related]
13. Enhanced delivery of paclitaxel liposomes using focused ultrasound with microbubbles for treating nude mice bearing intracranial glioblastoma xenografts.
Shen Y; Pi Z; Yan F; Yeh CK; Zeng X; Diao X; Hu Y; Chen S; Chen X; Zheng H
Int J Nanomedicine; 2017; 12():5613-5629. PubMed ID: 28848341
[TBL] [Abstract][Full Text] [Related]
14. Anti-cancer Antibody Trastuzumab-Melanotransferrin Conjugate (BT2111) for the Treatment of Metastatic HER2+ Breast Cancer Tumors in the Brain: an In-Vivo Study.
Nounou MI; Adkins CE; Rubinchik E; Terrell-Hall TB; Afroz M; Vitalis T; Gabathuler R; Tian MM; Lockman PR
Pharm Res; 2016 Dec; 33(12):2930-2942. PubMed ID: 27528392
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil recruitment and leukocyte response following focused ultrasound and microbubble mediated blood-brain barrier treatments.
Poon C; Pellow C; Hynynen K
Theranostics; 2021; 11(4):1655-1671. PubMed ID: 33408773
[No Abstract] [Full Text] [Related]
16. Delivery of DNA octahedra enhanced by focused ultrasound with microbubbles for glioma therapy.
Shen Y; Hu M; Li W; Chen Y; Xu Y; Sun L; Liu D; Chen S; Gu Y; Ma Y; Chen X
J Control Release; 2022 Oct; 350():158-174. PubMed ID: 35981634
[TBL] [Abstract][Full Text] [Related]
17. A systematic review of trastuzumab and lapatinib in the treatment of women with brain metastases from HER2-positive breast cancer.
Larsen PB; Kümler I; Nielsen DL
Cancer Treat Rev; 2013 Nov; 39(7):720-7. PubMed ID: 23481218
[TBL] [Abstract][Full Text] [Related]
18. Selective permeabilization of the blood-brain barrier at sites of metastasis.
Connell JJ; Chatain G; Cornelissen B; Vallis KA; Hamilton A; Seymour L; Anthony DC; Sibson NR
J Natl Cancer Inst; 2013 Nov; 105(21):1634-43. PubMed ID: 24108809
[TBL] [Abstract][Full Text] [Related]
19. Characterization of ultrasound-mediated delivery of trastuzumab to normal and pathologic spinal cord tissue.
Smith P; Ogrodnik N; Satkunarajah J; O'Reilly MA
Sci Rep; 2021 Feb; 11(1):4412. PubMed ID: 33627726
[TBL] [Abstract][Full Text] [Related]
20. Preliminary Investigation of Focused Ultrasound-Facilitated Drug Delivery for the Treatment of Leptomeningeal Metastases.
O'Reilly MA; Chinnery T; Yee ML; Wu SK; Hynynen K; Kerbel RS; Czarnota GJ; Pritchard KI; Sahgal A
Sci Rep; 2018 Jun; 8(1):9013. PubMed ID: 29899537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]